CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

Clinical trial NCT03569579 · COMPLETED

Trial details

NCT number: NCT03569579
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Diseases

Start date: 2018-04-16
Primary completion: 2018-05-21
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.